Navigation Links
Circassia Raises GBP15 Million ($25 Million) in Oversubscribed Investment Round
Date:12/11/2009

OXFORD, England, December 11 /PRNewswire/ --

- Investment Follows Successful Phase Ii Clinical Results With cat Allergy T-cell Vaccine

- Funding to Progress ToleroMune(R) T-cell Allergy Vaccines Into Late-Stage Development

Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced that it has completed a GBP15 million ($25 million) fundraising. The investment round, which was led by Imperial Innovations and supported by existing shareholders including Invesco Perpetual and Lansdowne Partners, was significantly oversubscribed and is the company's third successful fundraising. The investment follows recently announced positive phase II results with Circassia's ToleroMune(R) cat allergy T-cell vaccine. The financing will support the acceleration of the programme into late-stage development and advance the clinical development of Circassia's broader portfolio of novel allergy T-cell vaccines.

"The success of this funding round is a great vote of confidence in Circassia's unique allergy T-cell vaccine technology and the dedication of our team," said Steve Harris, Circassia's CEO. "Our most recent clinical results clearly demonstrate the potential of our ToleroMune(R) technology, as well as scientifically validating our novel use of T-cell vaccines to improve the treatment of allergy sufferers. This new investment recognises the importance of these results, and represents a strategic milestone in the development of Circassia's next generation allergy treatments."

About Circassia's allergy T-cell vaccines

Circassia's range of allergy T-cell vaccines is based on its proprietary ToleroMune(R) technology. This technology utilises allergen epitopes to generate regulatory T cells that suppress allergic immune responses. Clinical results with Circassia's cat allergy T-cell vaccine show that short treatment regimes can greatly reduce pat
'/>"/>

SOURCE Circassia Ltd
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Circassia Begins Phase II Clinical Trial With Ragweed Allergy Therapy
2. Circassias Allergy Therapy Begins Phase II Clinical Trial in Asthma Patients
3. Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment
4. Circassia Initiates Further Phase II Clinical Study of Toleromune(R) Anti-Allergy Technology
5. Circassia Achieves Successful Phase II Clinical Results With Toleromune(R) Anti-Allergy Technology
6. Apnex Medical, Inc. Raises Additional $14 Million
7. Cambridge-based Ligon Discovery Raises $1M in Seed Funding
8. FREE Drug Discount Card Saves Money on Prescriptions and Raises Funds for Americas Disabled Veterans
9. CareFusion Reports First Quarter Results, Raises Full-Year Outlook
10. NxStage(R) Reports Third Quarter 2009 Financial Results and Raises Revenue Guidance for Fiscal 2009
11. Cancer Diagnostics Company, On-Q-ity, Raises $21M in Series A Funding for the Development of Technologies to Personalize Cancer Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... Aug. 21, 2014 /CNW/ - The Canadian Epilepsy Alliance (CEA) ... series designed to educate children about the most common neurological ... Medikidz Explain Epilepsy comic series tells a fictional story ... middle school while living with epilepsy. "Despite ... is still so much misinformation and lack of awareness out ...
(Date:8/21/2014)... 2014 /PRNewswire-iReach/ -- Inc. magazine today ... third straight year, No. 349 in Health on ... of the nation,s fastest-growing private companies. The list ... important segment of the economy—America,s independent entrepreneurs. Companies ... LinkedIn, Zillow, and many other well-known names gained ...
(Date:8/21/2014)... , Aug. 21, 2014 /PRNewswire-iReach/ -- ScriptPro ... Alliance (HITRUST) under its Common Security Framework (CSF). ... Security and Privacy Manager, "We appreciate this rigorous, ... of commitment that this certification signifies. Our business ... ABOUT THE CSF CERTIFICATION PROCESS: ScriptPro,s internal ...
Breaking Medicine Technology:Action Heroes Harness Powers to Educate Children About Epilepsy 2Action Heroes Harness Powers to Educate Children About Epilepsy 3Carolina's HME Named for Third Straight Year to Inc. Magazine's List of America's Fastest-Growing Private Companies--the Inc. 5000 2Carolina's HME Named for Third Straight Year to Inc. Magazine's List of America's Fastest-Growing Private Companies--the Inc. 5000 3ScriptPro Achieves HITRUST Certification 2
(Date:8/23/2014)... August 23, 2014 Summer vacation is almost ... be back in session. While shopping for school supplies and ... weeks, Batzner encourages parents and students to also spend some ... bugs are excellent hitchhikers and thrive in heavily populated places,” ... makes classrooms and dorms the perfect settings for bed bugs ...
(Date:8/22/2014)... 2014 On Friday, Aug. 22, Liberty ... Health Sciences , hosting a ceremony in its courtyard ... government and public welfare. , The 162-member inaugural class ... (LUCOM) joined Liberty staff, faculty, and community leaders ... the new medical school. Classes began on Monday, Aug. ...
(Date:8/22/2014)... (PRWEB) August 23, 2014 Top ... many famous web hosting companies and highly recommended ... customers. , The manager of Top 10 Best ... a good dedicated server hosting supplier. Actually, these ... uptime, server speed and customer support. People can ...
(Date:8/22/2014)... 22, 2014 Buying a policy for different ... is unsure about available coverage types by insurers in the ... insurance policy pricing to the public using its sortable tool ... tool is free and is expected to promote the discounts ... public throughout the U.S. The system is designed to help ...
(Date:8/22/2014)... 23, 2014 Recently, iFitDress.com, a well-known ... collection of discounted wedding gowns . In addition ... all these new products are provided with low shipping ... happy to unveil the new wedding gowns. In our ... gowns for ladies to choose from. What’s more, all ...
Breaking Medicine News(10 mins):Health News:Expert Advice for a Bed Bug-Free School Year 2Health News:Liberty University Dedicates Its New Center for Medical and Health Sciences 2Health News:Liberty University Dedicates Its New Center for Medical and Health Sciences 3Health News:Liberty University Dedicates Its New Center for Medical and Health Sciences 4Health News:FatCow Reviews Released by Top10BestSEOHosting.com 2Health News:Principal Life Insurance Policies Now Quoted for Adults at Insurance Website Online 2Health News:Discounted Wedding Gowns For Sale At Leading Online Shop iFitDress.com 2
... JOLLA, Calif., March 19, 2012 Drug resistance is ... that was once providing some benefit simply stops working. ... how cancer cells develop resistance to a drug called ... a number of Phase I and Phase I/II clinical ...
... children leaving doctors, offices with an attention deficit hyperactivity ... years, according to a new Northwestern Medicine study. Over ... have begun treating an increasing number of these young ... was published in the March/April issue of the journal ...
... 19 (HealthDay News) -- The emergency room costs of treating ... more than half a million dollars a year at a ... The University of Wisconsin-Madison study included 954 ... before the start of the study, male participants drank an ...
... trained mouse immune systems to eradicate skin cancer from ... melanoma cells and a cousin of the rabies virus. ... version of the vesicular stomatitis virus to deliver a ... directly into tumors. In early studies, 60 percent of ...
... are living longer with and after a cancer diagnosis, ... and practices governing the care of survivorsan important emerging ... to gather these resources into an easily understandable plan ... of unique and very specific challenges," says Crystal S. ...
... Varicose veins are a cosmetic issue for most people, but ... for others, an expert says. "Twenty to 25 percent ... more advanced venous disease including skin changes or, occasionally, ulcerations," ... in Rochester, Minn., said in a clinic news release. ...
Cached Medicine News:Health News:Sanford-Burnham scientists unravel cancer drug's secret to resistance 2Health News:Sanford-Burnham scientists unravel cancer drug's secret to resistance 3Health News:Diagnosis of ADHD on the rise 2Health News:Excessive Drinking Costs U.S. Colleges Millions Annually 2Health News:Mayo Clinic researchers building melanoma vaccine to combat skin cancer 2Health News:Fox Chase Cancer Center leads efforts to establish national standards for survivorship care 2
... Stent System is a supportive .035" guide wire compatible ... mm in lengths of 18 mm, 28 mm, 38 ... diameters available in 12 and 16 mm lengths. ... lengths. Two "diameter specific" OMNILINK® stents were developed ...
... Response catheters comprise the world's broadest ... electrophysiology procedures. Their advanced catheter design ... torque response with a soft, atraumatic ... French sizes, Supreme and Response catheters ...
... left heart catheterization occurs when the initial ... sheath with an alternate curve while maintaining ... exchange has required a repeat septal puncture--complex ... overcome this problem with the unique PERRY ...
... comprise the world's broadest line of ... Their advanced catheter design and materials ... with a soft, atraumatic tip. Available ... Supreme and Response catheters provide outstanding ...
Medicine Products: